158 related articles for article (PubMed ID: 36296634)
1. Ultrasensitive Simultaneous Detection of Multiple Rare Modified Nucleosides as Promising Biomarkers in Low-Put Breast Cancer DNA Samples for Clinical Multi-Dimensional Diagnosis.
Yu Y; Pan HY; Zheng X; Yuan F; Zhou YL; Zhang XX
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296634
[TBL] [Abstract][Full Text] [Related]
2. A validated quantitative liquid chromatography-tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA.
Tsuji M; Matsunaga H; Jinno D; Tsukamoto H; Suzuki N; Tomioka Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():38-47. PubMed ID: 24568937
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
Godoy AT; Eberlin MN; Simionato AVC
Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
[TBL] [Abstract][Full Text] [Related]
4. Protonation-Suppression-Free LC-MS/MS Analysis for Profiling of DNA Cytosine Modifications in Adult Mice.
Mo J; Liang Z; Lu M; Wang H
Anal Chem; 2020 Jun; 92(11):7430-7436. PubMed ID: 32353227
[TBL] [Abstract][Full Text] [Related]
5. Sensitive and simultaneous determination of 5-methylcytosine and its oxidation products in genomic DNA by chemical derivatization coupled with liquid chromatography-tandem mass spectrometry analysis.
Tang Y; Zheng SJ; Qi CB; Feng YQ; Yuan BF
Anal Chem; 2015 Mar; 87(6):3445-52. PubMed ID: 25675106
[TBL] [Abstract][Full Text] [Related]
6. Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry.
Guo M; Liu D; Sha Q; Geng H; Liang J; Tang D
J Pharm Biomed Anal; 2019 Feb; 164():309-316. PubMed ID: 30412804
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
[TBL] [Abstract][Full Text] [Related]
8. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology.
Amalric A; Bastide A; Attina A; Choquet A; Vialaret J; Lehmann S; David A; Hirtz C
Crit Rev Clin Lab Sci; 2022 Jan; 59(1):1-18. PubMed ID: 34473579
[TBL] [Abstract][Full Text] [Related]
9. Discovery and validation of bladder cancer related excreted nucleosides biomarkers by dilution approach in cell culture supernatant and urine using UHPLC-MS/MS.
Chang Q; Chen P; Yin J; Liang G; Dai Y; Guan Y; Chen Y; Zhao Y; Lu YJ; Zhang L; Song D; Yuan H
J Proteomics; 2023 Jan; 270():104737. PubMed ID: 36174950
[TBL] [Abstract][Full Text] [Related]
10. Twins labeling derivatization-based LC-MS/MS strategy for absolute quantification of paired prototypes and modified metabolites.
Li W; Zhang P; Hou X; Tang T; Li S; Sun R; Zhang Z; Xu F
Anal Chim Acta; 2022 Feb; 1193():339399. PubMed ID: 35058011
[TBL] [Abstract][Full Text] [Related]
11. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.
Liu X; Lovell MA; Lynn BC
Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131
[TBL] [Abstract][Full Text] [Related]
12. Automated Identification of Modified Nucleosides during HRAM-LC-MS/MS using a Metabolomics ID Workflow with Neutral Loss Detection.
Ross RL; Yu N; Zhao R; Wood A; Limbach PA
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2785-2792. PubMed ID: 37948765
[TBL] [Abstract][Full Text] [Related]
13. A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.
Xu F; Zhou W; Cao J; Xu Q; Jiang D; Chen Y
Theranostics; 2017; 7(11):2849-2862. PubMed ID: 28824720
[TBL] [Abstract][Full Text] [Related]
14. A novel malic acid-enhanced method for the analysis of 5-methyl-2'-deoxycytidine, 5-hydroxymethyl-2'-deoxycytidine, 5-methylcytidine and 5-hydroxymethylcytidine in human urine using hydrophilic interaction liquid chromatography-tandem mass spectrometry.
Guo C; Xie C; Chen Q; Cao X; Guo M; Zheng S; Wang Y
Anal Chim Acta; 2018 Nov; 1034():110-118. PubMed ID: 30193624
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
16. Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism.
Willmann L; Erbes T; Krieger S; Trafkowski J; Rodamer M; Kammerer B
Anal Bioanal Chem; 2015 May; 407(13):3555-66. PubMed ID: 25736241
[TBL] [Abstract][Full Text] [Related]
17. Determination of dimethylated nucleosides in serum from colorectal cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
Cao X; Wang M; Huang Y; Zhang M; Zheng F; Zhang G; Su J; Yuan Y; Guo C
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123973. PubMed ID: 38142502
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis.
Vignon M; Bastide A; Attina A; David A; Bousquet P; Orti V; Vialaret J; Lehmann S; Periere DD; Hirtz C
J Periodontal Res; 2023 Oct; 58(5):959-967. PubMed ID: 37349891
[TBL] [Abstract][Full Text] [Related]
19. Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model.
Yu C; Zhang Q; Wang L; Zhang Y; Cui M; Bi K; Li D; Li Q
Talanta; 2022 Aug; 245():123452. PubMed ID: 35413629
[TBL] [Abstract][Full Text] [Related]
20. Ultrasensitive Determination of Rare Modified Cytosines Based on Novel Hydrazine Labeling Reagents.
Yu Y; Yuan F; Zhang XH; Zhao MZ; Zhou YL; Zhang XX
Anal Chem; 2019 Oct; 91(20):13047-13053. PubMed ID: 31507172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
